Cullinan Therapeutics Inc
CGEM7.940USD
+0.270+3.52%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
7.940USD+7.940After-hours (ET)
466.07MMarket Cap
LossP/E TTM
Cullinan Therapeutics Inc
7.940
+0.270+3.52%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2019Q4
FY2019Q3
Total revenue
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--18.94M
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--18.94M
----
----
----
----
Operating expenses
27.93%55.00M
21.02%55.05M
9.04%48.85M
33.03%50.03M
-31.50%42.99M
39.49%45.48M
50.52%44.80M
6.21%37.60M
92.17%62.76M
-5.06%32.61M
61.99%29.77M
113.24%35.41M
93.35%32.66M
17.74%34.35M
59.80%18.38M
--16.60M
--16.89M
485.92%29.17M
65.38%11.50M
--4.98M
--6.95M
R&D expenses
35.28%41.46M
16.20%40.49M
4.98%35.51M
32.38%36.26M
-41.17%30.65M
63.44%34.85M
71.85%33.82M
3.71%27.39M
112.32%52.10M
2.12%21.32M
55.21%19.68M
124.24%26.41M
97.63%24.54M
25.55%20.88M
27.91%12.68M
--11.78M
--12.41M
337.38%16.63M
87.89%9.91M
--3.80M
--5.28M
Depreciation, depletion, and amortization
0.00%76.00K
0.00%77.00K
-5.00%76.00K
-4.94%77.00K
5.56%76.00K
30.51%77.00K
788.89%80.00K
575.00%81.00K
453.85%72.00K
391.67%59.00K
-30.77%9.00K
-7.69%12.00K
-13.33%13.00K
-20.00%12.00K
-13.33%13.00K
--13.00K
--15.00K
-11.76%15.00K
-6.25%15.00K
--17.00K
--16.00K
Operating profit
-27.93%-55.00M
-21.02%-55.05M
-9.04%-48.85M
-33.03%-50.03M
31.50%-42.99M
-39.49%-45.48M
-50.52%-44.80M
-6.21%-37.60M
-92.17%-62.76M
5.06%-32.61M
-61.99%-29.77M
-113.24%-35.41M
-1690.70%-32.66M
-17.74%-34.35M
-59.80%-18.38M
---16.60M
--2.05M
-485.92%-29.17M
-65.38%-11.50M
---4.98M
---6.95M
Net non-operating interest income (expenses)
Non-operating interest income
15.58%6.58M
26.96%7.51M
42.59%8.38M
51.65%8.07M
26.29%5.69M
75.89%5.92M
149.89%5.88M
663.56%5.32M
2188.32%4.51M
2355.47%3.36M
1894.07%2.35M
302.89%697.00K
302.04%197.00K
73.42%137.00K
-36.22%118.00K
--173.00K
--49.00K
-68.65%79.00K
83.17%185.00K
--252.00K
--101.00K
Special income (expenses)
----
--0.00
100.00%0.00
----
----
--0.00
---440.00K
-100.00%0.00
----
--0.00
--0.00
--275.08M
----
----
----
----
---681.00K
----
----
----
----
Other non-operating income (expenses)
-93.18%-85.00K
105.13%6.00K
-149.44%-89.00K
-204.35%-72.00K
-141.12%-44.00K
-139.26%-117.00K
--180.00K
128.63%69.00K
--107.00K
7350.00%298.00K
100.00%0.00
-2912.50%-241.00K
100.00%0.00
133.33%4.00K
---2.00K
---8.00K
---2.00K
-200.00%-12.00K
-100.00%0.00
---4.00K
--3.00K
Income before tax
-29.89%-48.50M
-19.77%-47.53M
-3.51%-40.56M
-30.47%-42.03M
35.78%-37.34M
-37.10%-39.69M
-42.94%-39.18M
-113.41%-32.21M
-79.12%-58.14M
15.38%-28.95M
-50.13%-27.41M
1560.76%240.13M
-2387.53%-32.46M
-17.52%-34.21M
-61.38%-18.26M
---16.44M
--1.42M
-515.22%-29.11M
-65.19%-11.31M
---4.73M
---6.85M
Income tax
----
100.83%117.00K
----
----
----
-660.06%-14.12M
100.00%0.00
-100.00%0.00
100.00%0.00
---1.86M
---2.52M
--66.07M
---19.57M
----
----
----
----
----
----
----
----
Income after tax
-29.89%-48.50M
-86.39%-47.65M
-3.51%-40.56M
-30.47%-42.03M
35.78%-37.34M
5.63%-25.56M
-57.42%-39.18M
-118.51%-32.21M
-350.99%-58.14M
20.81%-27.09M
-36.32%-24.89M
1158.85%174.06M
-1008.53%-12.89M
-17.52%-34.21M
-61.38%-18.26M
---16.44M
--1.42M
-515.22%-29.11M
-65.19%-11.31M
---4.73M
---6.85M
Net income from continuous operations
-29.89%-48.50M
-86.39%-47.65M
-3.51%-40.56M
-30.47%-42.03M
35.78%-37.34M
5.63%-25.56M
-57.42%-39.18M
-118.51%-32.21M
-350.99%-58.14M
20.81%-27.09M
-36.32%-24.89M
1158.85%174.06M
-1008.53%-12.89M
-17.52%-34.21M
-61.38%-18.26M
---16.44M
--1.42M
-515.22%-29.11M
-65.19%-11.31M
---4.73M
---6.85M
Other net gains and losses
----
---117.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Income attributable to non-controlling interests
100.00%0.00
100.00%0.00
--0.00
--0.00
-7.26%-192.00K
-475.16%-1.76M
100.00%0.00
100.00%0.00
77.46%-179.00K
81.91%-306.00K
90.54%-86.00K
-3.74%-833.00K
-153.32%-794.00K
-122.63%-1.69M
37.57%-909.00K
---803.00K
--1.49M
-369.14%-760.00K
-447.37%-1.46M
---162.00K
---266.00K
Net income attributable to controlling interests
-30.56%-48.50M
-100.17%-47.65M
-3.51%-40.56M
-30.47%-42.03M
35.91%-37.15M
11.12%-23.80M
-57.97%-39.18M
-118.42%-32.21M
-379.10%-57.96M
17.63%-26.78M
-42.96%-24.80M
1218.56%174.90M
-17182.86%-12.10M
-14.70%-32.51M
-76.00%-17.35M
---15.64M
---70.00K
-520.40%-28.35M
-49.75%-9.86M
---4.57M
---6.58M
Net income attributable to common shareholders
-30.56%-48.50M
-100.17%-47.65M
-3.51%-40.56M
-30.47%-42.03M
35.91%-37.15M
11.12%-23.80M
-57.97%-39.18M
-118.42%-32.21M
-379.10%-57.96M
17.63%-26.78M
-42.96%-24.80M
1218.56%174.90M
-17182.86%-12.10M
-14.70%-32.51M
-76.00%-17.35M
---15.64M
---70.00K
-520.40%-28.35M
-49.75%-9.86M
---4.57M
---6.58M
Basic earnings per share
4.67%-0.82
-46.20%-0.81
24.17%-0.70
5.32%-0.76
39.38%-0.86
5.00%-0.56
-68.60%-0.92
-120.69%-0.81
-423.27%-1.42
23.41%-0.59
-36.16%-0.54
1179.22%3.90
-16204.19%-0.27
-11.61%-0.76
-67.73%-0.40
---0.36
--0.00
-520.39%-0.68
-49.75%-0.24
---0.11
---0.16
Diluted earnings per share
4.67%-0.82
-46.20%-0.81
24.17%-0.70
5.32%-0.76
39.38%-0.86
5.00%-0.56
-68.60%-0.92
-121.38%-0.81
-423.27%-1.42
23.41%-0.59
-36.16%-0.54
1144.14%3.77
-16204.19%-0.27
-11.61%-0.76
-67.73%-0.40
---0.36
--0.00
-520.39%-0.68
-49.75%-0.24
---0.11
---0.16
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
